LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,090 | -34.4% | 32,745 | -59.6% | 0.00% | – |
| Q4 2022 | $41,297 | -8.2% | 81,133 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | -27.4% | 81,133 | -3.4% | 0.00% | – |
| Q2 2022 | $62,000 | -39.8% | 83,958 | 0.0% | 0.00% | – |
| Q1 2022 | $103,000 | +12.0% | 83,958 | +8.7% | 0.00% | – |
| Q4 2021 | $92,000 | -43.2% | 77,208 | -1.0% | 0.00% | – |
| Q3 2021 | $162,000 | -28.0% | 77,955 | +4.8% | 0.00% | – |
| Q2 2021 | $225,000 | – | 74,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 166,667 | $124,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 99,644 | $74,000 | 0.05% |
| Almanack Investment Partners, LLC. | 248,084 | $185,000 | 0.02% |
| Warberg Asset Management LLC | 14,500 | $11,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 16,948 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 49 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 25,794 | $19,000 | 0.00% |
| STATE STREET CORP | 35,956 | $28,000 | 0.00% |
| MORGAN STANLEY | 71,054 | $53,000 | 0.00% |
| Citadel Advisors | 30,063 | $23,000 | 0.00% |